Valeant Announces Q2 2017 Financial Results Date And Conference Call Details


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


LAVAL, Quebec, July 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) today announced that it plans to release second quarter 2017 financial results on Tuesday, Aug. 8, 2017. The Company will host a conference call and live webcast at 8:00 a.m. EDT to discuss the results and provide a business update. All materials will be made available on the investor relations portion of the corporate website before the start of the conference call.

Conference Call Details

 

Date

 

Tuesday, Aug. 8, 2017

Time

8:00 a.m. EDT

Webcast

http://ir.valeant.com/events-and-presentations

Participant Event Dial-in

(877) 876-8393 (North America)


(443) 961-0178 (International)

Participant Passcode

35736021

Replay Dial-in

(855) 859-2056 (North America)


(404) 537-3406 (International)

Replay Passcode

31833 (replay available until Oct. 8, 2017)

About Valeant
Valeant Pharmaceuticals International, Inc. (TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

 

Investor Contacts:



Arthur Shannon

Elif McDonald


arthur.shannon@valeant.com

elif.mcdonald@valeant.com


514-856-3855

514-856-3855


877-281-6642 (toll free)

877-281-6642 (toll free)


Media Contact:  


Lainie Keller


lainie.keller@valeant.com


908-927-0617


 

View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-announces-q2-2017-financial-results-date-and-conference-call-details-300485451.html

SOURCE Valeant Pharmaceuticals International, Inc.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!